Cabaletta Bio
biopharmaceutical company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases. .
Launch date
Employees
Market cap
$201m
Enterprise valuation
$5m (Public information from Sep 2024)
Share price
$4.7 CABA
Radnor Township Pennsylvania (HQ)
Authorizing premium user...